loading

Summit Therapeutics Inc Aktie (SMMT) Neueste Nachrichten

pulisher
07:00 AM

Summit Therapeutics to Present at Upcoming Investor Conferences - FinancialContent

07:00 AM
pulisher
04:18 AM

What institutional flow reveals about Summit Therapeutics Inc.Swing Trade & Smart Investment Allocation Tips - newser.com

04:18 AM
pulisher
Nov 03, 2025

Summit Therapeutics (SMMT) Is Down 6.4% After $513M Shelf Filing and Ivonescimab Clinical Updates—Has The Bull Case Changed? - Yahoo Finance

Nov 03, 2025
pulisher
Nov 03, 2025

A Look at Summit Therapeutics (SMMT) Valuation Following Positive HARMONi Trial Results and Regulatory Progress - Yahoo Finance

Nov 03, 2025
pulisher
Nov 03, 2025

Is Summit Therapeutics Inc. showing signs of accumulation2025 Geopolitical Influence & Stepwise Swing Trade Plans - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

What MACD and RSI say about Summit Therapeutics Inc.2025 Short Interest & Accurate Technical Buy Alerts - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Can Summit Therapeutics Inc. hit a new high this monthJuly 2025 Trends & Community Consensus Picks - newser.com

Nov 03, 2025
pulisher
Nov 02, 2025

Is Summit Therapeutics Inc. stock reversal real or fakeMarket Trend Report & Weekly Market Pulse Alerts - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

1 Monster Stock in the Making to Buy and Hold - AOL.com

Nov 02, 2025
pulisher
Nov 02, 2025

Summit Therapeutics PLC (NASDAQ:SMMT) Receives Consensus Rating of "Moderate Buy" from Brokerages - MarketBeat

Nov 02, 2025
pulisher
Nov 01, 2025

News impact scoring models applied to Summit Therapeutics Inc.Portfolio Value Report & Weekly Hot Stock Watchlists - newser.com

Nov 01, 2025
pulisher
Oct 31, 2025

Insiders Are Snapping Up These 2 Stocks — and Analysts Like What They See - Yahoo Finance

Oct 31, 2025
pulisher
Oct 31, 2025

Should you hold or exit Summit Therapeutics Inc. now2025 Volume Leaders & High Conviction Investment Ideas - newser.com

Oct 31, 2025
pulisher
Oct 31, 2025

Overall Survival Data from HARMONi-A, Featuring Ivonescimab in Combination with Chemotherapy vs. Chemotherapy in 2L+ Treatment of Patients with EGFRm NSCLC in China, to be Showcased at SITC 2025 - Business Wire

Oct 31, 2025
pulisher
Oct 31, 2025

Applying sector rotation models to Summit Therapeutics Inc.2025 Breakouts & Breakdowns & Weekly Chart Analysis and Trade Guides - newser.com

Oct 31, 2025
pulisher
Oct 31, 2025

Summit Therapeutics (SMMT) Aims for FDA Nod for Ivonescimab in N - GuruFocus

Oct 31, 2025
pulisher
Oct 30, 2025

Jefferies Cuts Summit Therapeutics (SMMT) Price Target, Keeps Buy Rating - Insider Monkey

Oct 30, 2025
pulisher
Oct 30, 2025

Summit Therapeutics (SMMT) Releases Financial Results and Updates on Operational Progress for Q3 2025 - Insider Monkey

Oct 30, 2025
pulisher
Oct 30, 2025

Summit Therapeutics Inc.Common Stock (NQ: SMMT - FinancialContent

Oct 30, 2025
pulisher
Oct 30, 2025

13 Stocks to Buy with Exponential Growth Heading into 2026 - Insider Monkey

Oct 30, 2025
pulisher
Oct 30, 2025

10 Stocks Under $20 to Buy According to Analysts - Insider Monkey

Oct 30, 2025
pulisher
Oct 30, 2025

Summit Therapeutics (SMMT) files for 26.68M share offering by selling stockholders - StreetInsider

Oct 30, 2025
pulisher
Oct 29, 2025

Why Wall Street Is Backing These 3 Comeback Stocks - Investing.com

Oct 29, 2025
pulisher
Oct 29, 2025

Patterns Watch: Is Summit Therapeutics Inc. stock a safe haven asset2025 Volume Leaders & Weekly High Return Stock Forecasts - fcp.pa.gov.br

Oct 29, 2025
pulisher
Oct 28, 2025

Co-CEO & Executive Chairman of Summit Therapeutics Picks Up 2.5% More Stock - simplywall.st

Oct 28, 2025
pulisher
Oct 28, 2025

Co-CEO & Executive Chairman of Summit Therapeutics Robert Duggan Buys 2.5% More Shares - Yahoo Finance

Oct 28, 2025
pulisher
Oct 28, 2025

Insider Spends US$262m Buying More Shares In Summit Therapeutics - 富途牛牛

Oct 28, 2025
pulisher
Oct 28, 2025

Can Summit Therapeutics Inc. stock outperform in 2025 bull marketEarnings Overview Summary & Real-Time Volume Analysis Alerts - Fundação Cultural do Pará

Oct 28, 2025
pulisher
Oct 28, 2025

Analyzing Summit Therapeutics Inc. with risk reward ratio charts2025 Price Targets & High Return Stock Watch Alerts - newser.com

Oct 28, 2025
pulisher
Oct 28, 2025

Allianz Asset Management GmbH Decreases Stock Holdings in Summit Therapeutics PLC $SMMT - MarketBeat

Oct 28, 2025
pulisher
Oct 28, 2025

What margin trends mean for Summit Therapeutics Inc. stock2025 Top Decliners & Fast Exit/Entry Strategy Plans - fcp.pa.gov.br

Oct 28, 2025
pulisher
Oct 27, 2025

Summit Therapeutics proves InvestingPro’s Fair Value accuracy with 40% return By Investing.com - Investing.com South Africa

Oct 27, 2025
$37.40
price down icon 0.12%
$28.93
price up icon 0.31%
$100.87
price down icon 0.65%
$104.19
price up icon 0.09%
biotechnology ONC
$310.10
price down icon 0.62%
$186.49
price up icon 0.07%
Kapitalisierung:     |  Volumen (24h):